Free Design Audit Available - Click Here for Details

New Soldier® High Flow Microcatheter Granted FDA Clearance

FDA Clears Soldier Microcatheter for Localized Drug Delivery in Vascular Interventions
New Soldier® High Flow Microcatheter Granted FDA Clearance

SUNNYVALE, Calif.–(BUSINESS WIRE)– Embolx Inc., a leading medical technology company developing microcatheters for arterial embolization procedures, is thrilled to announce that the U.S. Food and Drug Administration (FDA) has granted clearance for the Soldier® High Flow Microcatheter, advancing localized drug delivery in vascular interventions.

This press release features multimedia. View the full release here:

The Soldier microcatheter is a cutting-edge medical device created using the same Ultra-Thin Wall (UTW) technology and advanced design initially developed for its flagship product Sniper®. UTW technology allows microcatheters to be smaller in outer diameter yet maintain the largest internal lumens improving flow rates by almost two times. Using multiple discrete longitudinal sections, the advanced design provides exceptional pushability, torquability, and trackability. With FDA clearance, Embolx introduces a new microcatheter platform technology that is now the basis for a pipeline of new products.

Sign up for Blog Updates